TBI remained significantly associated with reduced adjusted risks of grade 3 to 4 aGVHD and moderate-severe cGVHD.

This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license.

for the treatment of acute myeloid leukemia (“AML”). Fast Track designation is a process designed to streamline the development and accelerate the assessment of drugs that target serious conditions ...

Researchers determine whether mutations in the Omicron NTD influence its potential to stimulate myeloid cells and enhance ... defeating chronic myelogenous leukemia, which tends to affect older ...

Our innovations in this area include a low-cost method of testing for chronic myeloid leukemia, a blood cancer, using a drop of blood on a paper card. Through a Fred Hutch partnership with the Max ...

Myeloproliferative neoplasms are blood cancers that affect myeloid stem cells. Treatment can involve targeted medications or careful monitoring. Myeloproliferative disorders are a group of cancers ...

These cancers include esophageal carcinoma (ESCA), gastric cancer (GC), glioma, laryngeal squamous cell carcinoma (LSCC), acute myeloid leukemia (AML), lung adenocarcinoma (LUAD), nasopharyngeal ...

Once the dilated colon is identified, the clinician must assess the severity of the patient's condition. Patients who appear clinically stable should be treated conservatively. In general, the ...

Background: This study aims to identify the hub genes and immune-related pathways in acute myeloid leukemia (AML) to provide new theories for immunotherapy. Methods: We use bioinformatics methods to ...